APA (7th ed.) Citation

JC, L., MP, Z., J, F., A, T., FS, C., DH, C., & RK, M. (2025). Myeloid ADAM17 induces ST2+ T regulatory cells that limit obesity-induced metabolic inflammation through changes in both membrane and soluble TNF. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 192, 118627. https://doi.org/10.1016/j.biopha.2025.118627

Chicago Style (17th ed.) Citation

JC, Lownik, Zellner MP, Farrar J, Tharakan A, Celi FS, Conrad DH, and Martin RK. "Myeloid ADAM17 Induces ST2+ T Regulatory Cells That Limit Obesity-induced Metabolic Inflammation Through Changes in Both Membrane and Soluble TNF." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 192 (2025): 118627. https://doi.org/10.1016/j.biopha.2025.118627.

MLA (9th ed.) Citation

JC, Lownik, et al. "Myeloid ADAM17 Induces ST2+ T Regulatory Cells That Limit Obesity-induced Metabolic Inflammation Through Changes in Both Membrane and Soluble TNF." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 192, 2025, p. 118627, https://doi.org/10.1016/j.biopha.2025.118627.